HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Husain Yar Khan Selected Research

Anaplastic Thyroid Carcinoma

12/2019Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Husain Yar Khan Research Topics

Disease

18Neoplasms (Cancer)
12/2023 - 12/2012
3Adenocarcinoma
12/2023 - 01/2020
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 01/2022
2Carcinogenesis
01/2020 - 12/2012
1Disease Progression
12/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Lymphoma (Lymphomas)
12/2021
1Prostatic Neoplasms (Prostate Cancer)
06/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021
1Neoplasm Metastasis (Metastasis)
03/2020
1Anaplastic Thyroid Carcinoma
12/2019
1Thyroid Neoplasms (Thyroid Cancer)
12/2019
1Breast Neoplasms (Breast Cancer)
12/2015
1Carcinoma (Carcinomatosis)
12/2012

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2020
4selinexorIBA
12/2023 - 01/2020
4CopperIBA
06/2016 - 12/2012
3sotorasibIBA
12/2023 - 01/2022
3130-nm albumin-bound paclitaxelIBA
12/2023 - 01/2020
3GemcitabineFDA Link
12/2023 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
02/2016 - 12/2012
3IonsIBA
02/2016 - 12/2012
3Reactive Oxygen Species (Oxygen Radicals)IBA
02/2016 - 12/2012
3PolyphenolsIBA
08/2015 - 12/2012
2adagrasibIBA
12/2023 - 03/2023
2Exportin 1 ProteinIBA
12/2023 - 06/2021
2Calcium Release Activated Calcium ChannelsIBA
03/2020 - 01/2020
2AntioxidantsIBA
06/2016 - 02/2016
2TeaIBA
02/2016 - 08/2015
2nizwasideIBA
01/2016 - 12/2015
1ProteomeIBA
12/2023
1AlbuminsIBA
12/2023
1Protein Isoforms (Isoforms)IBA
03/2023
1devimistatIBA
01/2023
1Niacinamide (Nicotinamide)FDA LinkGeneric
12/2021
1NAD (NADH)IBA
12/2021
1KPT-9274IBA
12/2021
1p21-Activated KinasesIBA
12/2021
1Adenosine Triphosphate (ATP)IBA
12/2021
1TransferasesIBA
12/2021
1EltanexorIBA
06/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2021
1Nuclear Proteins (Protein, Nuclear)IBA
06/2021
1PyrazinesIBA
07/2020
1CalciumIBA
03/2020
1RP4010IBA
03/2020
1Drug CombinationsIBA
12/2019
1Complement System Proteins (Complement)IBA
12/2019
1Tyrosine Kinase InhibitorsIBA
12/2019
1lenvatinibIBA
12/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2018
1Peptide Hydrolases (Proteases)FDA Link
10/2018
1apogossypoloneIBA
06/2016
1GossypolIBA
06/2016
1PhytochemicalsIBA
02/2016
1pregnane glycosideIBA
01/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2015
1Hydroxyl RadicalIBA
08/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2014
1ResveratrolIBA
03/2014
1ApigeninIBA
03/2014
1LuteolinIBA
03/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2012

Therapy/Procedure

7Therapeutics
12/2023 - 02/2016
2Oral Administration
03/2023 - 01/2022
1Radiotherapy
01/2023
1Castration
06/2021